NISSAY ASSET MANAGEMENT CORP /JAPAN
Position in RVMD — Revolution Medicines, Inc.
CIK 869589
Tokyo, M0
Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,963,593
+$2,172,248 QoQ
Shares Held
21,164
+14.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#249
of 685 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISSAY ASSET MANAGEMENT CORP /JAPAN holds $81,366,812 across 7 Biotechnology names. RVMD ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,743 | $37,623,820 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,636 | $19,102,771 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39,482 | $11,885,266 | |
| 4 | RVMD |
Revolution Medicines, Inc.
This page
|
21,164 | $3,963,593 | |
| 5 | RPRX |
Royalty Pharma plc
|
56,729 | $3,180,795 | |
| 6 | INSM |
INSMED Inc
|
28,233 | $3,010,202 | |
| 7 | INCY |
Incyte Corp
|
22,939 | $2,600,365 |
All Filings in RVMD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,963,593 | 21,164 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,791,345 | 18,420 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||